Skip to main content

Advertisement

Log in

HIV Treatment Adherence and Sexual Functioning

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

To our knowledge, no studies have considered the bidirectional relationship between HIV infected patients’ social/sexual lives and HAART adherence. To determine it’s potential impact the study sample consisted of 135 men starting HAART and being followed for 6 months. Twenty percent of men enrolled in the study self-reported non-adherence. Non-adherent patients reported a greater number and severity of adverse effects such as gastrointestinal and body changes. All participants were aware of these risks, requested support, and were advised by the health care providers. As many as 26% of the HIV infected men, at the second visit, reported sexual dysfunction and none received information regarding the possibility of this side effect. Of importance, patients reporting sexual dysfunction, were more likely to report not being fully adherent to the medication (RR = 2.46 95% CI 1.3–4.7; P = 0.04). Of most concern, none of the men reported looking for medical advice

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Ammassari, A., Trotta, M., Murri, R., Castelli, F., Narciso, P., & Noto, P., et al. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndromes, 31, S123–S127.

    PubMed  Google Scholar 

  • Aikens, J. E., Nease, D. E., Jr., Nau, D. P., Klinkman, M. S., & Schwenk, T. L. (2005). Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Annals of Family Medicine, 3, 23–30.

    Article  PubMed  Google Scholar 

  • Badawi, A. F., Cavalieri, E. L., & Rogan, E. G. (2001). Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. Metabolism, 50, 1001–1003.

    Article  PubMed  CAS  Google Scholar 

  • Chesney, M. (2003). Adherence to HAART regimens. AIDS Patient Care STDs, 17, 169–177.

    Article  PubMed  Google Scholar 

  • Colebunders, R., Moerman, F., & Noestlinger, C. (2006). Unexpected improvement of sexual dysfunction during atazanavir therapy. AIDS, 20(8), 1209–1210.

    Article  PubMed  CAS  Google Scholar 

  • Collier, A. C., Coombs, R. W., Schoenfeld, D. A., Bassett, R. L., Timpone, J., & Baruch, A., et al. (1996). Treatment of human immunodeficiency virus infection with saquinavir, zidovudine and zalcitabine. New England Journal of Medicine, 334, 1011–1017.

    Article  PubMed  CAS  Google Scholar 

  • Collazos, J., Martinez, E., Mayo, J., & Ibarra, S. (2002). Sexual hormones in HIV-infected patients: The influence of antiretroviral therapy. AIDS, 16, 934–937.

    Article  PubMed  CAS  Google Scholar 

  • Collins, E., Wagner, C., & Walmsley, S. (2000). Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Readers, 10, 546–550.

    CAS  Google Scholar 

  • Cove, J., & Petrak, J. (2004). Factors associated with sexual problems in HIV-positive gay men. International Journal of STD and AIDS, 15, 732–736.

    Article  PubMed  Google Scholar 

  • DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment. Archives of Internal Medicine, 160, 2101–2107.

    Article  PubMed  CAS  Google Scholar 

  • Dinsmore, W. (2004). Treatment of erectile dysfunction. International Journal of STD and AIDS, 15, 215–221.

    Article  PubMed  Google Scholar 

  • Fleming M. (2000). Screening and Brief Intervention in Primary Care Settings. Available at: http://www.niaaa.nih.gov/publications/arh28–2/57–62.htm.

  • Goldstein, I. (2000). The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. American Journal Cardiology, 86, 41f–45f.

    Article  CAS  Google Scholar 

  • Gordillo, V., Amo, J. D., Soriano, V., & Gonzalez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763–1769.

    Article  PubMed  CAS  Google Scholar 

  • Guaraldi, G., Murri, R., Orlando, G., Orlandi, E., Sterrantino, G., Borderi, M., & Grosso, C., et al. (2003). Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART. HIV Clinical Trials, 4, 99–106.

    Article  PubMed  Google Scholar 

  • Halkitis, P. N. (2002). HIV treatment in the 21st century: The reality of adherence. Psychology AIDS, 31, 1–2.

    Google Scholar 

  • Hammer, S. M., Kathleen, E. S., Hughes, M. D., Grimes, J. M., & Demeter, L. M., et al. (1997). A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4+ cell counts of 200 per cubic millimeter or less. New England Journal of Medicine, 337, 725–733.

    Article  PubMed  CAS  Google Scholar 

  • Haubrich, R. H., Little, S. J., Currier, J. S., Forthal, D. N., Kemper, C. A., & Beall, G. N., et al. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaboration Treatment Group. AIDS, 13, 1099–1107.

    Article  PubMed  CAS  Google Scholar 

  • Horne, R., Buick, D., Fisher, M., Leake, H., Cooper, V., & Weinman, J. (2004). Doubts about necessity and concerns about adverse effects: Identifying the types of beliefs that are associated with non-adherence to HAART. International Journal of STD and AIDS, 15, 38–44.

    Article  PubMed  Google Scholar 

  • Ippolito, G., Galati, V., Serraino, D., & Girardi, E. (2001). The changing picture of the HIV/AIDS epidemic. Ann NY Acad Sci , 946, 1–12.

    Article  PubMed  CAS  Google Scholar 

  • Katon, W. J. (2003). Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biological Psychiatry, 54, 216–226.

    Article  PubMed  Google Scholar 

  • Kim, A. A., Kent, C. K., & Klausner, J. D. (2002). Increased risk of HIV and sexually transmitted disease transmission among gay or bisexual men who use Viagra, San Francisco 2000–2001. AIDS, 16, 1425–1428.

    Article  PubMed  Google Scholar 

  • Klitzman, R. L., Kirshenbaum, S. B., Dodge, B., Remien, R. H., Ehrhardt, A. A., & Johnson, M. O., et al. (2004). NIMH Healthy Living Trial Group. Intricacies and inter-relationships between HIV disclosure and HAART: A qualitative study. AIDS Care, 16, 628–640.

    Article  PubMed  CAS  Google Scholar 

  • Lallemand, F., Salhi, Y., Linard, F., Giami, A., & Rozenbaum, W. (2002). Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors. Journal of Acquired Immune Deficiency Syndromes, 30, 187–190.

    PubMed  CAS  Google Scholar 

  • Lamba, H., Goldmeier, D., Mackie, N. E., & Scullard, G. (2004). Antiretroviral therapy is associated with sexual dysfunction and with increased serum oestradiol levels in men. International Journal of STD and AIDS, 15, 234–237.

    Article  PubMed  Google Scholar 

  • Loh, C., Leckband, S. G., Meyer, J. M., & Turner, E. (2004). Risperidone-induced retrograde ejaculation: Case report and review of the literature. International Clinical Psychopharmacology, 19, 111–112.

    Article  PubMed  Google Scholar 

  • Low-Beer, S., Yip, B., O’Shaughnessy, M. V., Hogg, R. S., & Montaner, J. S. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndromes, 23, 360–361.

    PubMed  CAS  Google Scholar 

  • Mehta, S., Moore, R. D., & Graham, N. (1997). Potential factors affecting adherence with HIV therapy. AIDS, 11, 1665–1670.

    Article  PubMed  CAS  Google Scholar 

  • Moatti, J. P., & Spire, B. (2003). Economic and socio-behavioral issues related to highly active antiretroviral therapies for HIV infection: the contribution of social science research. MS-Medecine Sciences, 19(8–9), 878–884.

    Google Scholar 

  • Monforte, A., Lepri, A., Rezza, G., Pezzotti, P., Antinori, A., & Phillips, A. N., et al. (2000). Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. AIDS, 14(5), 499–507.

    Article  Google Scholar 

  • Nurnberg, H. G. (2001). Managing treatment-emergent sexual dysfunction associated with serotonergic antidepressants: before and after sildenafil. Journal of Psychiatry Practice, 7, 92–108.

    Article  CAS  Google Scholar 

  • Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., & Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med, 133, 21–30.

    PubMed  CAS  Google Scholar 

  • Perkins, D. O. (2002). Predictors of non-compliance in patients with schizophrenia. Journal of Clinical Psychiatry, 63, 1121–1128.

    PubMed  Google Scholar 

  • Persson, A. G. (2003). New-fill and Humour: Dealing with body shape change. National Centre in HIV Social Research. The University of New South Wales. Paper presented at the 15th Annual Conference of the Australasian Society for HIV Medicine: Cairns.

  • Power, C., Selnes, O. A., Grim, J. A., & McArthur, J. C. (1995). HIV dementia scale: A rapid screening test. Journal of Acquired Immune Deficiency Syndrome Human Retrovirology, 8, 273–278.

    Article  CAS  Google Scholar 

  • Power, R., Tate, H. L., McGill, S. M., & Taylor, C. (2003). A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals. Sexually Transmitted Infections, 79, 137–141.

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez-Rosado, R., Jimenez-Nacher, I., Soriano, V., Anton, P., & Gonzalez-Lahoz, J. (1998). Virological failure and adherence to antiretroviral therapy in HIV-infected patients. AIDS, 12, 1112–1113.

    Article  PubMed  CAS  Google Scholar 

  • Saunders, J., Aasland, O., & Babor, T. (1993). Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. Addiction , 88, 791–804.

    Article  PubMed  CAS  Google Scholar 

  • Schrooten, W., Colebunders, R., Youle, M., Molenberghs, G., Dedes, N., & Koitz, G., et al. (2001). Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment. AIDS, 15, 1019–1023.

    Article  PubMed  CAS  Google Scholar 

  • Sheon, N., & Crosby, M. G. (2004). Ambivalent tales of HIV disclosure in San Francisco. Society of Science Medicine, 58(11), 2105–2118.

    Article  Google Scholar 

  • Solomon, H., Man, J., Gill, J., & Jackson, G. (2002). Viagra on the internet: Unsafe sexual practice. International Journal of Clinical Practice, 56, 403–404.

    PubMed  CAS  Google Scholar 

  • Steer, R. A., Cavalieri, T. A., Leonard, D. M., & Beck, A. T. (1999). Use of the Beck depression inventory for primary care to screen for major depression disorders. Gen Hosp Psychiatry, 21, 106–111.

    Article  PubMed  CAS  Google Scholar 

  • Tindall, B., Forde, S., Goldstein, D., Ross, M. W., & Cooper, D. A. (1994). Sexual dysfunction in advanced HIV disease. AIDS Care, 6, 105–107.

    Article  PubMed  CAS  Google Scholar 

  • Thompson, M., Gold, M., & Sathasivam, K. (2000). Adherence and relationship to antiretroviral efficacy in the HEART (NZT4006) study [abstract MoPpD1129]. In: Program and abstracts of the 13th International Conference on AIDS (Durban, South Africa) (172 p). Stockholm: International AIDS Society.

  • Trotta, M. P., Ammassari, A., Cozzi-Lepri, A., Zaccarelli, M., Castelli, F., & Narciso, P., et al. (2003). Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens. AIDS, 17(7), 1099–9102.

    Article  PubMed  Google Scholar 

  • Tsasis, P. (2001). Adherence assessment to highly active antiretroviral therapy. AIDS Patient Care STDs, 15, 109–115.

    Article  PubMed  CAS  Google Scholar 

  • von Giesen, H. J., Haslinger, B. A., Rohe, S., Koller, H., & Arendt, G. (2005). HIV dementia scale and psychomotor slowing—the best methods in screening for neuro-AIDS. Journal of Neuropsychiatry & Clinical Neurosciences, 17(2), 185–191.

    Google Scholar 

  • Wilks, S. D. (2003). Is sildenafil effective for antidepressant-related sexual dysfunction?–Patient Oriented Evidence That Matters: Practice recommendations from key studies [online] Available at: http://www.findarticles.com/p/articles/mi_m0689/is_4_52/ai_100171274.

Download references

Acknowledgment

The study was funded by the NIAAA of the United States (5R21AA13793-3 MJM).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Jose Miguez-Burbano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miguez-Burbano, M.J., Espinoza, L. & Lewis, J.E. HIV Treatment Adherence and Sexual Functioning. AIDS Behav 12, 78–85 (2008). https://doi.org/10.1007/s10461-006-9197-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-006-9197-0

Keywords

Navigation